US pharma giant Merck & Co (NYSE: MRK) today announced that the Phase III KEYNOTE-B96 trial, also known as ENGOT-ov65, met ...

Swiss pharma giant Novartis will spotlight key data across its oncology portfolio, including Kisqali (ribociclib), Scemblix ...

USA-based Inozyme Pharma, a biopharma developing innovative therapeutics for rare diseases that affect bone health and blood ...

The integration of genomics into the pharmaceutical industry has allowed researchers to better understand the genetic factors ...

New Jersey, USA-based cancer giant Merck & Co (NYSE: MRK) has announced it will unveil a comprehensive slate of new research ...

Marking the latest move to pledge to spend billions of dollars into the USA, French pharm major Sanofi (Euronext: SAN) ...

Japanese pharma major Takeda (TYO: 4502) announced that the US Food and Drug Administration (FDA) has accepted for priority ...

In a world where western firms increasingly seek to ingratiate themselves with Middle Eastern leaders and investors, a Saudi ...

US Department of Health and Human Services (HHS) Secretary Robert F Kennedy Jr (RFK Jr) has spoken in defence of his proposed ...

German pharmaceutical company Boehringer Ingelheim has entered a multi-year collaboration with Tempus AI (Nasdaq: TEM), ...

Aiming to expand its hepatology portfolio, UK pharma major GSK (LSE: GSK) yesterday announced that it has entered into an ...

London-based specialty pharmaceutical company CNX Therapeutics is set to fast-track its European growth strategy after being ...